Jason A Zell
Overview
Explore the profile of Jason A Zell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zell J, Taylor T, Albers C, Carmichael J, McLaren C, Wenzel L, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046763
After potentially curative treatment, colorectal cancer (CRC) patients remain at high risk for recurrence, second primary CRC, and high-risk adenomas. In combination with existing data, our previous findings provide a...
12.
Kumar P, Del Rosario M, Chang J, Ziogas A, Jafari M, Bristow R, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900256
Purpose: We analyzed adherence to the National Comprehensive Cancer Network treatment guidelines for anal squamous cell carcinoma in California and the associated impacts on survival. Methods: This was a retrospective...
13.
Hachey S, Sobrino A, Lee J, Jafari M, Klempner S, Puttock E, et al.
Transl Res
. 2022 Dec;
255:97-108.
PMID: 36481562
Accurately modeling tumor biology and testing novel therapies on patient-derived cells is critically important to developing therapeutic regimens personalized to a patient's specific disease. The vascularized microtumor (VMT), or "tumor-on-a-chip,"...
14.
Mesiti A, Brouwer J, Jafari M, Qiu Y, Wenzel L, Carmichael J, et al.
J Surg Res
. 2022 Dec;
283:658-665.
PMID: 36455419
Introduction: Early initiation of chemotherapy after surgery for colon cancer has survival benefits. Immediate adjuvant chemotherapy (IAC) involves giving chemotherapy during surgical resection and immediately postoperatively. This novel approach has...
15.
Del Rosario M, Chang J, Ziogas A, Clair K, Bristow R, Tanjasiri S, et al.
Dis Colon Rectum
. 2022 Jul;
66(9):1263-1272.
PMID: 35849491
Background: National Comprehensive Cancer Network guideline adherence improves cancer outcomes. In rectal cancer, guideline adherence is distributed differently by race/ethnicity, socioeconomic status, and insurance. Objective: This study aimed to determine...
16.
Marciano N, Kroening G, Dayyani F, Zell J, Lee F, Cho M, et al.
Cancers (Basel)
. 2022 May;
14(10).
PMID: 35626055
The discovery of and in the 1990s revolutionized the way we research and treat breast, ovarian, and pancreatic cancers. In the case of pancreatic cancers, germline mutations occur in about...
17.
Juat D, Hachey S, Billimek J, Del Rosario M, Nelson E, Hughes C, et al.
Oncologist
. 2022 Mar;
27(3):210-219.
PMID: 35274719
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. For the vast majority of patients with advanced CRC (ie, for those in whom metastatic tumors...
18.
Jafari M, Carmichael J, Dayyani F, McKinney C, Wenzel L, Zell J, et al.
Clin Colorectal Cancer
. 2022 Jan;
21(2):114-121.
PMID: 34980534
Background: The optimal timing of adjuvant chemotherapy (AC) in non-metastatic colon cancer is poorly defined. Delays in AC result in decreased survival. Effective cytotoxic treatments should be considered during the...
19.
Clair K, Wolford J, Zell J, Bristow R
Surg Oncol Clin N Am
. 2020 Nov;
30(1):69-88.
PMID: 33220810
This article addresses the role of surgery in the management of gynecologic cancers with liver metastases. The authors review the short-term and long-term outcomes of aggressive resection through retrospective and...
20.
Lumsdaine C, Liu-Smith F, Li X, Zell J, Lu Y
Am J Cancer Res
. 2020 Jul;
10(6):1888-1899.
PMID: 32642298
Recent studies have reported an increasing incidence of early onset colorectal cancer (CRC). Few studies compared the changing incidence of CRC by the major histological type, adenocarcinoma and neuroendocrine tumors...